Abstract
Cancer incidence is relatively low in sub-Saharan Africa (SSA), however, prognosis is expected to be poor in comparison with high-income countries. Comprehensive evidence is limited on the survival pattern of colorectal cancer patients in the region. We conducted a systematic review and meta-analysis to investigate the pattern of colorectal cancer survival in the region and to identify variation across countries and over time. We searched international databases MEDLINE, Scopus, Embase, Web of Science, ProQuest, CINAHL, and Google Scholar to retrieve studies that estimated survival from colorectal cancer in SSA countries from inception to December 31, 2021 without language restriction. Due to between-study heterogeneity, we performed a random-effects meta-analysis to pool survival rates. To identify study-level sources of variation, we performed subgroup analysis and meta-regression. Results are reported in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 2020 guideline and the protocol was registered in PROSPERO database (CRD42021246935). 23 studies involving 10,031 patients were included in the review, of which, 20 were included in the meta-analysis. The meta-analysis results showed that the pooled 1-, 2-, 3-, 4-, and 5-year survival rates in SSA were 0.74 (95% CI, 0.66–0.81), 0.50 (95% CI, 0.41–0.58), 0.36 (95% CI, 0.27–0.47), 0.31 (95% CI, 0.22–0.42), and 0.28 (95% CI, 0.19–0.38) respectively. Subgroup analyses indicated that the survival rate varied according to year of study, in which those conducted in recent decades showed relatively better survival. The 5-year survival was higher in middle-income SSA countries (0.31; 95%CI: 0.17–0.49) than low-income countries (0.20; 95%CI: 0.11–0.35), however, the difference was not statistically significant. In conclusion, survival from colorectal cancer is low in sub-Saharan Africa compared to other regions. Thus, intervention strategies to improve screening, early diagnosis and treatment of colorectal cancer should be developed and implemented to improve survival in the region.
Graphical Abstract
Highlights
- • The survival from colorectal cancer is low in SSA compared to other regions.
- • Improvement in survival is observed in recent decades, however, it is still very low in comparison with high-income regions.
- • Countries’ income level is associated with survival of colorectal cancer patients.
1Introduction
The share of non-communicable diseases (NCDs) to global morbidity and mortality is increasing. In 2030, NCDs are predicted to be responsible for more than three-quarter of global mortality , of which cancer is likely to be the most important contributor. In 2020, an estimated 19.3 million new cancer cases and 10.0 million deaths occurred, making cancers the second-leading cause of morbidity and mortality worldwide . Colorectal cancer is the third most commonly diagnosed and second-leading cause of cancer deaths worldwide, with nearly 2 million new cases and above a million deaths in 2020 .
In the past, NCDs including cancer were the disease priorities of developed countries, however, recently the burden is increasing in low- and middle-income countries (LMICs) and should be considered among major public health issues . Adopting a sedentary lifestyle, urbanization, cultural transition towards unhealthy behavior, and an increase in life expectancy in LMICs might be the possible reasons for an increasing burden of NCDs including cancer . Following an increase in individual income in LMICs, the dietary habit shifted towards unhealthy patterns such as an increased intake of fat, sugar, and animal-source packed foods , which are known risk factors of cancer . Furthermore, increasing industrialization in middle-income countries also contributes to the observed trend in cancer incidence and mortality . Low and low-middle socio-development index (SDI) countries have shown the largest increase in the number of cancer cases and deaths occurred from 2009 to 2019 . The sub-Saharan Africa (SSA) region in particular is in a demographic and epidemiologic transition marked by an increase in life expectancy due to a decline in mortality from communicable diseases leading to a more older population who are at higher risk of cancer . As a result, the cancer burden in the region is expected to increase by 85% in 2030 .
Existing challenges, including poor screening services, inadequate research, and limited population-based registry make the cancer burden to be underestimated in SSA and less attention is given in policies . The rise in prevalence of cancer in the region puts pressure on already overwhelmed healthcare and economic infrastructure, and poses additional challenges to the health service delivery . The mortality due to cancer is significantly higher in LMICs, accounting for nearly 70% of all cancer deaths . Particularly, people younger than 65 years of age are most commonly affected , leading to a greater economic impact as a result of premature mortality and lost years of productivity. In contrast to other regions, the share of cancer death in Asia (58.3%) and Africa (7.2%) are higher than the share of incidence 49.3% and 5.7% respectively, which could be due to the difference in the distribution of cancer types and higher case fatality rates in those regions .
The cancer prognosis in SSA is poor which could be due to delay in patients’ visit to healthcare facilities, inadequate access to diagnostic services, and minimal treatment options. Although investigating the survival pattern is crucial for patients and healthcare providers, comprehensive evidence is limited in SSA. Assessing survival patterns enables us to understand the prognosis over time and enables public health professionals and policy makers to understand the quality and effectiveness of care and treatments introduced. In this review, we synthesized the survival pattern of patients diagnosed with colorectal cancer in sub-Saharan Africa. Furthermore, we summarized the variation in survival pattern across time, country’s income level, and other study level factors.
Reviews
There are no reviews yet.